SCHEMBL8295491

SCHEMBL8295491

Oc1nc(-c2ccncc2)cc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCH P24723 2/20 0.52
PRKCE Q02156 2/20 0.52
DHODH Q02127 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 1/20 0.47
CYP2C9 P11712 5/20 0.44
CYP3A4 P08684 3/20 0.44
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
AR P10275 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
CDC7 O00311 2/20 0.42
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6382426 0.87 IDO1 (0.54) DHODHKDM4EALDH1A1MAPTHPGD
SCHEMBL9629001 0.82 TRPM4 (0.48) KDM4EALDH1A1MAPTHPGDCYP1A2
SCHEMBL2155064 0.81 CYP11B1 (0.61) DHODHKDM4ECYP2C9LMNACYP11B1
SCHEMBL10682024 0.81 MAPT (0.49) KDM4EALDH1A1MAPTHPGDCYP3A4
SCHEMBL7260213 0.79 IDO1 (0.47) DHODHKDM4EALDH1A1MAPTIDO1
SCHEMBL22201436 0.79 PRKCH (0.52) PRKCHPRKCEDHODHKDM4EALDH1A1
SCHEMBL16436810 0.77 PRKCH (0.51) PRKCHPRKCEDHODHKDM4EALDH1A1
SCHEMBL10674917 0.77 DHODH (0.61) DHODHKDM4EALDH1A1MAPTHPGD
SCHEMBL10882283 0.77 KDM4E (0.52) PRKCHPRKCEDHODHKDM4EALDH1A1
SCHEMBL8272630 0.77 SYK (0.52) KDM4EALDH1A1MAPTHPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687018-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-01-25 EP disclosed
WO-2005046712-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-05-26 WO disclosed